Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Tirzepatide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Flaxseed and Tirzepatide have evidence — compare verdict strength side-by-side.
30g (about 3-4 tablespoons) of ground/milled flaxseed daily
with-meals
Ground / milled flaxseed
Once-weekly subcutaneous injection, started at 2.5 mg and escalated by 2.5 mg every 4 weeks to a maintenance dose of 5, 10, or 15 mg (per the prescribing physician and approved indication)
any
Once-weekly subcutaneous injection (Mounjaro / Zepbound)
8-12 weeks
8-12 weeks
12 weeks
First 1-2 weeks
Weeks to months
Months (dose-escalated over ~20 weeks)
Weeks to months
Mostly during titration
Effects of flaxseed supplements on blood pressure: A systematic review and meta-analysis of controlled clinical trial.
Clin Nutr (2016) · Meta analysis · n=1302
15 trials (19 treatment arms), 1302 participants
Potent antihypertensive action of dietary flaxseed in hypertensive patients.
Hypertension (2013) · Rct · n=110
Double-blind, placebo-controlled RCT, 110 patients, 6 months
Flaxseed supplementation on glucose control and insulin sensitivity: a systematic review and meta-analysis of 25 randomized, placebo-controlled trials.
Nutr Rev (2018) · Meta analysis
25 RCTs (30 treatment arms)
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
N Engl J Med (2021) · Rct · n=1879
Open-label 40-week phase-3 head-to-head RCT (SURPASS-2) in 1879 patients with type 2 diabetes, tirzepatide 5/10/15 mg vs semaglutide 1 mg
Tirzepatide Once Weekly for the Treatment of Obesity.
N Engl J Med (2022) · Rct · n=2539
72-week phase-3 double-blind RCT (SURMOUNT-1) in 2539 adults with obesity (without diabetes), tirzepatide 5/10/15 mg vs placebo
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
N Engl J Med (2025) · Rct · n=751
Phase-3b open-label head-to-head RCT (SURMOUNT-5) in 751 adults with obesity but without diabetes, max-tolerated tirzepatide vs max-tolerated semaglutide
Tirzepatide has a higher evidence score (7.8/10 vs 6.5/10) and wins in 2 of 3 categories.
No known interactions between Flaxseed and Tirzepatide have been documented in our database. However, always consult a healthcare provider before combining supplements.